With increased litigation risk from regulators and private parties, including limited partners and stakeholders in portfolio companies, private equity firms should re-examine their professional liability insurance policies. “One size fits all” policies that are not sufficiently tailored to meet evolving business needs present a risk.

There are six key questions that fund sponsors should ask:

  • Are activities by regulators covered “claims,” and if so, what specific types of activities are covered by the policy?

Some coverage is triggered only by certain formalities of the enforcement process. However, responding to a regulator’s “informal” or “voluntary” requests for certain documents can be costly.

  • Are the exclusions from coverage for “insured versus insured” claims too broad?

Professional liability policies typically exclude from coverage claims brought by one insured against another insured. It is important to consider whether this exclusion should be “entity versus insured” rather than the broader “insured versus insured.”

  • Does the policy provide coverage for claims relating to failed portfolio company transactions?

The definition of “portfolio company” should be closely examined to ensure that it includes prospective portfolio companies.

  • Is there a clear order of priority between and among insurance policies and indemnification rights?

Sponsors should evaluate the “priority” of the GPL coverage relative to other insurance coverage, whether at the portfolio company level or the management company level, as well as the priority of the insurance coverage relative to indemnification obligations of the fund, the management company, and the portfolio companies.

  • Are the “defense and settlement” provisions too onerous?

Fund sponsors should consider requesting that this provision be scaled back to allow the sponsor to enter into settlements within the retention amount without the insurer’s consent.

  • Should the sponsor obtain stand-alone “cyberliability” insurance?

Private equity firms have begun purchasing cyberliability policies which typically supplement GPL policy coverage for regulatory response costs, data and network rebuilding, and recovery costs.

Read the full article.

*Reproduced with permission from Law360.com.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Timothy W. Mungovan Timothy W. Mungovan

Tim Mungovan is the Chair of Proskauer.  He is also the immediate past chair of the Firm’s Litigation Department and head of the Securities Litigation practice.

His practice is focused on securities, commercial litigation, governance, and bankruptcy-related matters. He has a national reputation…

Tim Mungovan is the Chair of Proskauer.  He is also the immediate past chair of the Firm’s Litigation Department and head of the Securities Litigation practice.

His practice is focused on securities, commercial litigation, governance, and bankruptcy-related matters. He has a national reputation for advising sponsors of private investment funds (hedge, private equity, private credit and venture capital) in a wide variety of matters, including litigation, governance, securities, fiduciary obligations, and regulatory enforcement.

Chambers USA describes Tim as “an extraordinary lawyer who is a fierce and very talented litigator. He is extremely knowledgeable, responsive and client-oriented.” Best Lawyers in America lauds Tim’s experience, integrity, work ethic, communications and courtroom skills. Tim has been listed in the “Top 100 Lawyers” in Massachusetts, and Benchmark Litigation has continually recognized Tim as a Litigation Star in Massachusetts.

Over the last six years, Tim has been the lead litigator representing the Financial Oversight and Management Board for Puerto Rico in the historic restructuring of Puerto Rico’s debts. The scale and complexity of this restructuring has resulted in one of the most active litigation dockets in the U.S. Almost every aspect of the litigation involved matters of first impression in part because the restructuring is governed by the Puerto Rico Oversight, Management, and Economic Stability Act, which was enacted for Puerto Rico in 2016.  The track record of success speaks for itself:  in the more than 150 lawsuits filed, Tim and the Proskauer team have prevailed in almost 95% of the cases.

Tim is recognized nationally for his experience in private fund litigation and disputes, having focused on the industry for more than 25 years.  As part of that focus, Tim created and is the lead editor of Proskauer’s blog on Private Equity litigation, The Capital Commitment.

Photo of Michael R. Hackett Michael R. Hackett

Mike Hackett is a partner in the Litigation Department and Co-Head of the Asset Management Litigation practice. An experienced litigator and trial lawyer, Mike’s practice focuses on complex commercial litigation, with a particular emphasis on asset management, financial services, M&A, shareholder, and life…

Mike Hackett is a partner in the Litigation Department and Co-Head of the Asset Management Litigation practice. An experienced litigator and trial lawyer, Mike’s practice focuses on complex commercial litigation, with a particular emphasis on asset management, financial services, M&A, shareholder, and life sciences disputes.

A significant portion of Mike’s practice concerns disputes and regulation involving private funds, including private equity, venture capital, hedge, real estate and private credit funds, as well as their sponsors, partners, investors, portfolio companies, and officers and directors. Mike’s experience representing private fund clients runs the gamut, from control contests within advisers, to disputes between limited partners and general partners, to representation of investment advisers in connection with regulatory examinations, investigations and enforcement matters. Mike routinely represents funds, fund sponsors, portfolio companies, and their officers and directors, including in significant post-closing M&A disputes.

Mike also litigates high-stakes commercial disputes in the life sciences and financial services areas, including for established pharmaceutical and biotechnology companies, emerging and innovative start-ups, asset managers, and other private capital investors, in areas such as M&A, breach of contract, indemnification, fraud, contested earnouts and royalties, securities and capital markets, and corporate governance.

Mike has been recognized by Chambers USA and was named a “Rising Star” by Massachusetts Super Lawyers.